ON THE REGULATION AND CONTROL OF FIBRINOLYSIS: EDWARD KOWALSKI MEMORIAL LECTURECOLLEN D.1980; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1980; VOL. 43; NO 2; PP. 77-89; BIBL. 162 REF.Article

IDENTIFICATION AND SOME PROPERTIES OF A NEW FAST-REACTING PLASMIN INHIBITOR IN HUMAN PLASMA.COLLEN D.1976; EUROP. J. BIOCHEM.; GERM.; DA. 1976; VOL. 69; PP. 209-216; BIBL. 24 REF.Article

POTENTIAL OF TISSUE-TYPE PLASMINOGEN ACTIVATOR AS A THROMBOLYTIC AGENTCOLLEN D.1983; LYON MEDICAL; ISSN 0024-7790; FRA; DA. 1983; VOL. 249; NO 9; PP. 327-329; ABS. FRE; BIBL. 15 REF.Article

Biochemical and preclinical studies on improved thrombolytic therapy, research contributions during the period 1986-1990COLLEN, D.Bulletin et mémoires de l'Académie Royale de Médecine de Belgique. 1992, Vol 147, Num 11-12, pp 441-449, issn 0377-8231Article

Synergism of thrombolytic agents: investigational procedures and clinical potentialCOLLEN, D.Circulation (New York, N.Y.). 1988, Vol 77, Num 4, pp 731-735, issn 0009-7322Article

THE PRESENCE AND RELEASE OF ALPHA ₂-ANTIPLASMIN FROM HUMAN PLATELETSPLOW EF; COLLEN D.1981; BLOOD; ISSN 0006-4971; USA; DA. 1981; VOL. 58; NO 6; PP. 1069-1074; BIBL. 28 REF.Article

FAST-ACTING PLASMIN INHIBITOR IN HUMAN PLASMA.COLLEN D; WIMAN B.1978; BLOOD; USA; DA. 1978; VOL. 51; NO 4; PP. 563-569; BIBL. 1 P. 1/2Article

MEASUREMENT OF PLASMIN-ANTIPLASMIN COMPLEX IN PLASMA. A COMPARISON OF LATEX AGGLUTINATION, LATEX AGGLUTINATION INHIBITION AND HEMAGGLUTINATION INHIBITION TESTS.BINI A; COLLEN D.1978; THROMBOSIS RES.; G.B.; DA. 1978; VOL. 12; NO 3; PP. 389-395; BIBL. 6 REF.Article

Tissue-type plasminogen activator therapeutic potential in thrombotic disease statesCOLLEN, D.Drugs (Basel). 1986, Vol 31, Num 1, pp 1-5, issn 0012-6667Article

Human tissue-type plasminogen activator: from the laboratory to the bedsideCOLLEN, D.Circulation (New York, N.Y.). 1985, Vol 72, Num 1, pp 18-20, issn 0009-7322Article

DEGRADATION OF THE APOPROTEIN A-I POLYPEPTIDE CHAIN OF HUMAN HIGH DENSITY LIPOPROTEIN BY HUMAN PLASMINLIJNEN HR; COLLEN D.1981; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1981; VOL. 24; NO 1-2; PP. 151-156; BIBL. 15 REF.Article

NEUTRALIZATION OF HUMAN EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR IN HUMAN PLASMA: NO EVIDENCE FOR A SPECIFIC INHIBITORKORNINGER C; COLLEN D.1981; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1981; VOL. 46; NO 3; PP. 662-665; BIBL. 20 REF.Article

PURIFICATION AND CHARACTERIZATION OF BOVINE COAGULATION FACTOR XII (HAGEMAN FACTOR).CLAEYS H; COLLEN D.1978; EUROP. J. BIOCHEM.; DEU; DA. 1978; VOL. 87; NO 1; PP. 69-74; BIBL. 23 REF.Article

COMPARISON OF THE REACTIONS OF NEUTRAL GRANULOCYTE PROTEASES WITH THE MAJOR PLASMA PROTEASE INHIBITORS AND WITH ANTIPLASMIN.OHLSSON K; COLLEN D.1977; SCAND. CLIN. LAB. INVEST.; NORWAY; DA. 1977; VOL. 37; NO 4; PP. 345-350; BIBL. 16 REF.Article

SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION.COLLEN D; VERSTRAETE M.1983; CIRCULATION; ISSN 0009-7322; USA; DA. 1983; NO 68; 2; PP. 462-465; BIBL. 8 REF.Article

PURIFICATION AND CHARACTERIZATION OF THE PLASMINOGEN ACTIVATOR SECRETED BY HUMAN MELANOMA CELLS IN CULTURERIJKEN DC; COLLEN D.1981; J. BIOL. CHEM.; ISSN 0021-9258; USA; DA. 1981; VOL. 256; NO 13; PP. 7035-7041; BIBL. 37 REF.Article

ALPHA ₂-ANTIPLASMIN CONSUMPTION AND FIBRINOGEN BREAKDOWN DURING THROMBOLYTIC THERAPYCOLLEN D; VERSTRAETE M.1979; THROMBOSIS RES.; GBR; DA. 1979; VOL. 14; NO 4-5; PP. 631-639; BIBL. 23 REF.Article

MOLECULAR MECHANISM OF PHYSIOLOGICAL FIBRINOLYSIS.WIMAN B; COLLEN D.1978; NATURE; G.B.; DA. 1978; VOL. 272; NO 5653; PP. 549-550; BIBL. 19 REF.Article

NEOANTIGENIC EXPRESSION IN ENZYME-INHIBITOR COMPLEXES. A MEANS TO DEMONSTRATE ACTIVATION OF ENZYME SYSTEMS.COLLEN D; DE COCK F.1978; BIOCHIM. BIOPHYS. ACTA; NLD; DA. 1978; VOL. 525; NO 1; PP. 287-290; BIBL. 7 REF.Article

MOLECULAR BIOLOGY OF HUMAN PLASMINOGEN. I. PHYSICOCHEMICAL PROPERTIES AND MICROHETEROGENEITY. = BIOLOGIE MOLECULAIRE DU PLASMINOGENE. I. PROPRIETES PHYSICO-CHIMIQUES ET MICRO-HETEROGENEITECOLLEN D; DE MAEYER L.1975; THROMBOSIS DIATHESIS HAEMORRHAG.; ALLEM.; DA. 1975; VOL. 34; NO 2; PP. 396-402; BIBL. 2 P.Article

Fibrin-selective thrombolytic therapy for acute myocardial infarctionCOLLEN, D.Circulation (New York, N.Y.). 1996, Vol 93, Num 5, pp 857-865, issn 0009-7322Article

Report of the meeting of the subcommittee on fibrinolysis, San Diego, CA, USA, July 13, 1985COLLEN, D.Thrombosis and haemostasis. 1985, Vol 54, Num 4, issn 0340-6245, 893Article

Coronary thrombolysis with tissue-type plasminogen activator: prospective reviewCOLLEN, D.Texas Heart Institute journal. 1984, Vol 11, Num 4, pp 344-347, issn 0730-2347Article

STUDIES ON THE SPECIFIC FIBRINOLYTIC EFFECT OF HUMAN EXTRINOIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR IN HUMAN BLOOD AND IN VARIOUS ANIMAL SPECIES IN VITROKORNIGER C; COLLEN D.1981; THROMB. HAEMOST.; ISSN 0340-6245; DEU; DA. 1981; VOL. 46; NO 2; PP. 561-565; BIBL. 17 REF.Article

PURIFICATION AND CHARACTERIZATION OF HUMAN ANTIPLASMIN THE FAST-ACTING PLASMIN INHIBITOR IN PLASMA.WIMAN B; COLLEN D.1977; EUROP. J. BIOCHEM.; GERM.; DA. 1977; VOL. 78; NO 1; PP. 19-26; BIBL. 33 REF.Article